TAK1 Inhibition Leads to RIPK1-Dependent Apoptosis in Immune-Activated Cancers

To identify novel therapeutic approaches, researchers performed CRISPR/Cas9 knockout screens and discovered TGFβ activated kinase (TAK1) as a selective survival factor in a significant fraction of glioma stem cells.